Selection of excipients for the purpose of creating an intranasal gel of interleukin-1 receptor antagonist β (IL-1ra)
There is a negative dynamic of the spread of cerebrovascular diseases, which often lead to disability or death in patients in the world, today. Such diseases are characterized by acute disorders of cerebral metabolism and blood circulation, against the background of other chronic pathologies. More t...
Main Authors: | B. S. Burlaka, I. F. Bielenichev, V. V. Hladyshev, E. V. Suprun, H. P. Lysianska |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2020-08-01
|
Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
Subjects: | |
Online Access: | http://pharmed.zsmu.edu.ua/article/view/207190/207504 |
Similar Items
-
Thermogravimetric studies of a nasal preparation with an interleukin-1β (IL-1Ra) antagonist
by: B. S. Burlaka
Published: (2021-03-01) -
Study of excipients influence on the noopept releasing from the nasal dosage form
by: B. S. Burlaka, et al.
Published: (2019-12-01) -
Optimization of the composition of a nasal medicine with interleukin-1 antagonist β
by: B. S. Burlaka
Published: (2021-02-01) -
Study of surfactants influence on the noopept releasing from the nasal dosage form
by: B. S. Burlaka, et al.
Published: (2020-05-01) -
Differences in the Levels of Interleukin-1β (IL-1β) and Interleukin-1 Receptor Antagonist (IL-1ra) in Children with Status Epilepticus and Febrile Seizure
by: Fita Shofiyah, et al.
Published: (2017-09-01)